149 related articles for article (PubMed ID: 24253896)
1. Effect of StarD13 on colorectal cancer proliferation, motility and invasion.
Nasrallah A; Saykali B; Al Dimassi S; Khoury N; Hanna S; El-Sibai M
Oncol Rep; 2014 Jan; 31(1):505-15. PubMed ID: 24253896
[TBL] [Abstract][Full Text] [Related]
2. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
[TBL] [Abstract][Full Text] [Related]
3. StarD13 differentially regulates migration and invasion in prostate cancer cells.
Jaafar L; Fakhoury I; Saab S; El-Hajjar L; Abou-Kheir W; El-Sibai M
Hum Cell; 2021 Mar; 34(2):607-623. PubMed ID: 33420961
[TBL] [Abstract][Full Text] [Related]
4. StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion.
Hanna S; Khalil B; Nasrallah A; Saykali BA; Sobh R; Nasser S; El-Sibai M
Int J Oncol; 2014 May; 44(5):1499-511. PubMed ID: 24627003
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
[TBL] [Abstract][Full Text] [Related]
6. The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.
Khalil BD; Hanna S; Saykali BA; El-Sitt S; Nasrallah A; Marston D; El-Sabban M; Hahn KM; Symons M; El-Sibai M
Exp Cell Res; 2014 Feb; 321(2):109-22. PubMed ID: 24333506
[TBL] [Abstract][Full Text] [Related]
7. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
8. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
10. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
11. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
12. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
13. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
14. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
[TBL] [Abstract][Full Text] [Related]
15. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
16. StarD13: a potential star target for tumor therapeutics.
Jaafar L; Chamseddine Z; El-Sibai M
Hum Cell; 2020 Jul; 33(3):437-443. PubMed ID: 32274657
[TBL] [Abstract][Full Text] [Related]
17. StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42.
Abdellatef S; Fakhoury I; Haddad MA; Jaafar L; Maalouf H; Hanna S; Khalil B; El Masri Z; Hodgson L; El-Sibai M
Eur J Cell Biol; 2022 Jan; 101(1):151197. PubMed ID: 34958986
[TBL] [Abstract][Full Text] [Related]
18. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
19. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
20. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
